Position in ARVN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,248
New position
Shares Held
1,474
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#158
of 198 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Evelyn Partners Group Ltd holds $223,703 across 8 Biotechnology names. ARVN ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,300 | $70,902 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
175 | $52,680 | |
| 3 | FHTX |
Foghorn Therapeutics Inc.
|
7,100 | $34,648 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
47 | $23,346 | |
| 5 | MRNA |
Moderna, Inc.
|
304 | $21,289 | |
| 6 | ARVN |
Arvinas, Inc.
This page
|
1,474 | $12,248 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
450 | $6,642 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
199 | $1,948 |
All Filings in ARVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,248 | 1,474 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||